Ambys Medicines
South San Francisco
About Ambys Medicines
Ambys Medicines is a biotechnology company focused on discovering and developing regenerative and restorative therapies. Ambys Medicines is working to fundamentally transform the lives of people suffering from severe liver diseases by creating breakthrough therapies capable of restoring liver function, preventing the progression of liver disease, and treating the devastating complications of liver failure.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $187.0M
- Funding stage: M&A
- Last round: Series A (Dec 2021)
- Website: ambys.com
- Phone: (650) 481-7660
Industries & Categories
Biotechnology, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/ambys-medicines-168651 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.